-
Mantha, S, Goldman, DA, Devlin, SM, Lee, J-W, Zannino, D, Collins, M, Douer, D, Iland, HJ, Litzow, MR, Stein, EM, et al.
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
Blood
129(13)
:
1763 -1767
2017
view publication
-
Spittal, MJ, Carlin, JB, Currier, D, Downes, M, English, DR, Gordon, I, Pirkis, J, Gurrin, L.
The Australian longitudinal study on male health sampling design and survey weighting: implications for analysis and interpretation of clustered data.
BMC Public Health
16(Suppl 3)
:
1062
2016
view publication
-
Iland, HJ, Collins, M, Bradstock, K, Supple, SG, Catalano, A, Hertzberg, M, Browett, P, Grigg, A, Firkin, F, Campbell, LJ, et al.
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
The Lancet Haematology
2(9)
:
e357 -e366
2015
view publication
-
Shah, K, Marvelde, LT, Collins, M, De Abreu Lourenco, R, D’Costa, I, Coleman, A, Fua, T, Liu, C, Rischin, D, Lau, E, et al.
Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.
Oral Oncology
51(5)
:
529 -535
2015
view publication
-
Lim, ABM, Storek, J, Beligaswatte, A, Collins, M, Tacey, M, Williamson, T, Mason, K, Li, E, Chaudhry, MA, Russell, JA, et al.
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis.
Bone Marrow Transplantation
50(4)
:
566 -572
2015
view publication